- In June 2024, TRI-K Industries, Inc. introduced TRICare™ CG, a next-generation amino acid-based multifunctional ingredient tailored for modern personal care formulations. Developed using a patented green chemistry process, TRICare CG is solvent-free, biodegradable, and designed to support the skin and scalp microbiome while replacing outdated preservative systems. Derived from capryloyl glycine, it offers benefits like sebum regulation, reduction in redness and pore size, and targeted action against acne- and dandruff-causing organisms. Suitable for both rinse-off and leave-on products, it reflects the growing trend of microbiome-friendly, sustainable skincare solutions powered by amino acid technology
- In June 2024, AmiLyfe BioScience LLC acquired key assets from Entrinsic Bioscience, including over 180 patents and trademarks, as well as the full enterade® brand portfolio. This strategic acquisition enhances AmiLyfe’s footprint in the health and wellness sector, leveraging Entrinsic’s pioneering work in natural amino acid-based therapeutics. The deal includes clinically validated products like enterade oncology®, used in over 700 cancer centers worldwide, and proprietary oral rehydration solutions (ORS). With this move, AmiLyfe aims to accelerate innovation through its AI-driven Maestro™ platform, targeting gut health, hydration, respiratory wellness, and skincare
- In November 2024, Be Well by Kelly launched its Essential Amino Acids supplement—a leucine-rich, plant-based blend featuring all nine essential amino acids (EAAs). Designed to support muscle protein synthesis, metabolism, and brain health, the formula includes Amino L40®, a proprietary mix of L-Leucine, L-Lysine Acetate, L-Valine, L-Isoleucine, L-Threonine, L-Phenylalanine, L-Methionine, L-Histidine, and L-Tryptophan. With a minimum of 40% leucine content, the supplement is vegan, sugar-free, gluten-free, and low-calorie, aligning with the rising demand for clean, functional nutrition. It’s manufactured in the U.S. using meticulously sourced ingredients from Japan
- In October 2024, Evonik unveiled a major reconfiguration of its Health Care division, signaling a strategic pivot toward becoming a system solutions supplier within its Nutrition & Care segment. As part of this transformation, Evonik announced plans to discontinue keto acid production in Hanau, Germany by the end of 2025, affecting around 260 employees. Meanwhile, the company is evaluating strategic alternatives—including partnerships or divestiture—for its keto and pharmaceutical amino acid production sites in Ham, France and Wuming, China. These changes reflect Evonik’s sharpened focus on high-growth areas such as lipids for mRNA and gene therapies, drug delivery systems, and cell culture ingredients
- In July 2024, Alpino Health Foods made waves in India’s wellness market by launching the country’s first 100% peanut-based protein powder, formulated in the Netherlands. Each scoop delivers 24g of high-quality protein and 5.1g of BCAAs, using only natural ingredients with no artificial additives, sweeteners, or preservatives. Sweetened with monk fruit and completely lactose-free, this innovation caters to the growing demand for clean-label, plant-based nutrition. Designed to taste like whey while being easier to digest, it’s ideal for fitness enthusiasts, athletes, and anyone seeking a sustainable, allergen-friendly protein source
